- Report
- January 2026
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- March 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 154 Pages
Global
From €2540EUR$2,900USD£2,204GBP
- Report
- July 2025
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- January 2026
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 270 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 340 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 130 Pages
Global
From €4160EUR$4,750USD£3,611GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more